Primmune Therapeutics
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
21
organic / mo
Sign up free to see all 4 verified contacts at Primmune Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- JB
Jenna Bobarykin
Executive Assistant · General Business & Management
EmailPhone - PR
Paulo Rangel
Chief Business Officer and Co-founder · Other
EmailPhone - SZ
Scott Zook
Senior Vice President Global Manufacturing · Other
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Primmune Therapeutics
3 distinct titles indexed · top 3 shown.
- 1chief business officer and co-founder
- 1executive assistant
- 1senior vice president global manufacturing
Sign up to unlock all 4 contacts at Primmune Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Primmune Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.